Clearstead Advisors’s Regenxbio RGNX Stock Holding History

Clearstead Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01K	Buy	+84	New	+$697	﹤0.01%	2684
2026 Q1	–	Sell	-32	Closed	-$461	–	2732
2025 Q4	$461	Sell	32 -431	-93%	-$5.37K	﹤0.01%	2317
2025 Q3	$4.47K	Buy	463 +457	+7,617%	+$4.04K	﹤0.01%	2197
2025 Q2	$50	Buy	+6	New	+$50	﹤0.01%	2671
2023 Q3	–	Sell	-100	Closed	-$2K	–	1511
2023 Q2	$2K	Hold	100	–	–	﹤0.01%	1155
2023 Q1	$1.89K	Hold	100	–	–	﹤0.01%	1143
2022 Q4	$2.27K	Hold	100	–	–	﹤0.01%	1071
2022 Q3	$3K	Hold	100	–	–	﹤0.01%	1045
2022 Q2	$2K	Hold	100	–	–	﹤0.01%	1127
2022 Q1	$3K	Hold	100	–	–	﹤0.01%	1157
2021 Q4	$3K	Hold	100	–	–	﹤0.01%	1074
2021 Q3	$4K	Hold	100	–	–	﹤0.01%	1054
2021 Q2	$4K	Hold	100	–	–	﹤0.01%	930
2021 Q1	$3K	Hold	100	–	–	﹤0.01%	930
2020 Q4	$5K	Hold	100	–	–	﹤0.01%	807
2020 Q3	$3K	Hold	100	–	–	﹤0.01%	792
2020 Q2	$4K	Hold	100	–	–	﹤0.01%	689
2020 Q1	$3K	Buy	+100	New	+$4.17K	﹤0.01%	688

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Clearstead Advisors's RGNX Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Regenxbio (RGNX) in Q2 2026: 84 shares worth $1.01K. The stake represents ﹤0.01% of the portfolio and ranks #2684 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in RGNX as recently as Q4 2025.

Clearstead Advisors first reported a position in RGNX in Q1 2020 and has held it in 18 quarters since. The position peaked at $5K in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Clearstead Advisors held 84 shares of Regenxbio worth $1.01K as of Q2 2026.
Regenxbio was a new Clearstead Advisors position in Q2 2026.
Regenxbio made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2684 holding.
Clearstead Advisors first reported a position in Regenxbio in Q1 2020 and has held it in 18 quarters since.
Clearstead Advisors's Regenxbio position peaked at $5K in Q4 2020.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.